ABC
FOLD

Associated Banc-Corp’s Amicus Therapeutics FOLD Stock Holding History

Associated Banc-Corp’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-248
Closed -$6K – 516
2020
Q4 		$6K Hold
248
– – ﹤0.01% 468
2020
Q3 		$4K Hold
248
– – ﹤0.01% 474
2020
Q2 		$4K Hold
248
– – ﹤0.01% 455
2020
Q1 		$2K Buy
+248
New +$2.36K ﹤0.01% 574

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Associated Banc-Corp's FOLD Position: Q1 2021 in Review

Associated Banc-Corp sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 248 shares — an estimated $6K sold.

Associated Banc-Corp first reported a position in FOLD in Q1 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 259 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • Associated Banc-Corp reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 248 Amicus Therapeutics shares in Q1 2021, an estimated $6K.
  • Associated Banc-Corp first reported a position in Amicus Therapeutics in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Amicus Therapeutics position peaked at $6K in Q4 2020.
  • 259 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.